Physician profile
Stuart B Stoll
NPI 1912017161
$672,680.57
in general payments reported to CMS, 2019-2025
17 companies · $264 in 2025
The $264 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,239 · 2020: $507 · 2021: $638 · 2022: $325K · 2023: $345K · 2024: $888 · 2025: $264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $344K · Food and Beverage: $1,431 · Travel and Lodging: $14.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $344,326.47 |
| Food and Beverage | $1,430.75 |
| Travel and Lodging | $14.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $669,334.73 | 2019-2023 | |
| Carl Zeiss Meditec USA, INC. | $820.24 | 2021-2024 | Quatera 700, Callisto Eye, Iolmaster 700 |
| Alcon Vision LLC | $562.58 | 2019-2025 | Clareon, Lensx |
| Carl Zeiss Meditec, INC. | $551.63 | 2019-2023 | |
| Microsurgical Technology, INC. | $414.93 | 2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $389.63 | 2019 | |
| Lumibird Medical INC. | $118.85 | 2025 | |
| Novartis Pharmaceuticals Corporation | $90.58 | 2019 | |
| Sun Pharmaceutical Industries INC. | $78.52 | 2019-2022 | |
| Staar Surgical Company | $78.14 | 2019 | |
| Eyevance Pharmaceuticals LLC | $59.20 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $43.00 | 2019 | |
| Abbvie INC. | $32.02 | 2025 | |
| Allergan, INC. | $30.80 | 2020 | |
| Dutch Ophthalmic, USA | $30.33 | 2024 | Tissueblue, Eva, Combined Machine |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $29.55 | 2022 | |
| Quidel Corporation | $15.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Stoll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.